PAHO/EQUATOR Guidelines will help make study results fit for publication and practical use

21 July 2010

The Pan American Health Organization (PAHO) revealed last week that it is partnering with the EQUATOR Network to improve reporting on research for health in the Americas through the use of guidelines that promote greater accuracy and transparency.

Under an agreement signed this month, the PAHO will translate EQUATOR's guidelines on the reporting of research results and promote their use for the benefit of PAHO member countries in Latin America. The goal of the partnership is to make more research write-ups fit for publication and use in policymaking and clinical practice.

"Complete, accurate, and transparent reporting is an integral part of responsible research conduct," said EQUATOR Network chairman Doug Altman, adding: "Reporting guidelines like the CONSORT Statement help to improve the quality of research reports." The CONSORT (Consolidated Standards of Reporting Trials) Statement is an evidence-based, minimum set of recommendations for reporting randomized controlled trials.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical